Amgen

NPLATE

Manufacturer:

Amgen

Nplate HCPCS:

J2796

HCPCS Code Descriptor:

Injection, romiplostim, 10 micrograms

Category:

J Code

Nplate NDCs:

55513-0222-01, 55513-0221-01, 55513-0223-01

Primary Type:

Oncology Colony Stimulating Factor

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Nplate:

NPLATE is an Oncology Colony Stimulating Factor drug manufactured by Amgen and administered via the Subcutaneous route of administration. The J Code: J2796 is aligned to the drug NPLATE.

Nplate is a type of bone marrow stimulant that may be used to help treat chronic immune thrombocytopenic purpura, also known as ITP, a condition is caused by a lack of platelets in the blood. Nplate is a man-made form of a protein that occurs naturally in the body. This protein increases the production of platelets, cells that help with blood clotting in the body.

ACCESS PRICING AND MORE BY REGISTERING

J2796 Added Date:

January 1, 2010

J2796 Effective Date:

January 1, 2010

J2796 Termination Date:

HCPCS Active

Nplate billing and coding information can be found through Amgen at the link below:
Nplate patient assistance information can be found through Amgen’s Amgen Safety Net Foundation at the URL: http://www.amgensafetynetfoundation.com
NPLATE prescribing information can be found at the link below:
Information regarding NPLATE’s side effects can be found at MedlinePlus